A novel approach to recognition of Alzheimer's and Parkinson's diseases: random subspace ensemble classifier based on deep hybrid features with a super-resolution image
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.This study introduces an AI deep hybrid network for diagnosing Alzheimer's and Parkinson's diseases from MRI scans. The model achieved high accuracy, showing potential for early disease detection and clinical diagnostic assistance.
Area Of Science
- Neuroscience
- Medical Imaging
- Artificial Intelligence
Background
- Neurodegenerative diseases like Alzheimer's and Parkinson's pose significant diagnostic challenges.
- Artificial intelligence (AI) offers promising avenues for improving early diagnosis and classification accuracy.
- AI-driven analysis of medical images, particularly MRI, can enhance patient access to timely treatments.
Purpose Of The Study
- To develop and evaluate an AI-based auto-diagnosis system for Alzheimer's disease, Parkinson's disease, and healthy individuals using MRI scans.
- To leverage deep learning techniques for accurate classification of neurodegenerative conditions.
- To assess the potential of AI in providing diagnostic assistance in clinical settings.
Main Methods
- A deep hybrid network combining a convolutional neural network (CNN) and an ensemble classifier was designed.
- A very deep super-resolution neural network was employed to enhance the resolution of MRI images.
- Low and high-level features were extracted using the hybrid CNN, followed by classification with a k-nearest neighbor (KNN)-based random subspace ensemble classifier.
Main Results
- The proposed AI model achieved high performance on a 3-class dataset of MRI images.
- Key performance metrics included 99.11% accuracy, 98.75% sensitivity, 99.54% specificity, 98.65% precision, and 98.70% F1-score.
- These results demonstrate the model's effectiveness in distinguishing between Alzheimer's disease, Parkinson's disease, and healthy controls.
Conclusions
- The developed AI system shows significant potential for accurate and efficient auto-diagnosis of Alzheimer's and Parkinson's diseases.
- The hybrid deep learning approach effectively utilizes MRI features for classification.
- The study highlights the value of AI in supporting clinical decision-making for neurodegenerative diseases.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
